In Other News

• Oversensitive COVID-19 Tests Detecting Dead Coronavirus Cells, Driving False Positives and Reinfections

• Researchers Identify ‘Nanobodies’ That Can Block Novel Coronavirus from Entering Human Cells

• COVID-19 Vaccine Developers to Issue Joint Public Pledge Against Premature Launch Before Proving Safety and Effectiveness

• Pfizer Could Seek FDA Emergency Use Authorization for COVID-19 Vaccine in October

• Novavax COVID-19 Vaccine Phase 1 Data Reaffirms Safety Profile and Ability to Elicit Immune Response

• J&J’s Lead COVID-19 Vaccine Candidate Prevents Severe Disease in Pre-Clinical Studies

• Roche Receives FDA EUA for Cobas SARS-CoV-2 & Influenza A/B Test for Use on Cobas 6800/8800 Systems

• Chest X-Rays Can Aid in Rapid Diagnosis of COVID-19, Find Radiologists

• Researchers Identify New Possible Entry Points for SARS-CoV-2 into Human Bodies

• High-Powered Microscopic Images Reveal Startlingly High SARS-CoV-2 Viral Loads on Human Respiratory Surfaces

• NIH Offers USD 129.3 Million in Scale-Up and Manufacturing Support for New Set of COVID-19 Testing Technologies

• WHO Recommends Corticosteroids for Treatment of Critically Ill COVID-19 Patients After New Findings Emerge

• Sanofi and GSK Begin Phase 1/2 Trial of COVID-19 Vaccine Candidate with Aim to Move into Phase 3 by 2020 End

• Next-Generation Lymph Node Targeting COVID-19 Vaccine Promises Enduring T Cell Immunity

• New Promega XpressAmp Direct Amplification Reagents Allow COVID-19 Testing Labs to Skip RNA Extraction

• MicroGEM Awarded Over USD 40 Million by NIH to Fast-Track Rapid, No-Lab COVID-19 Saliva Test

• Combining PCR and Antibody Tests at POC Dramatically Increases COVID-19 Detection in Hospitalized Patients

• COVID-19 Vaccine Trials Could Be Halted Early in Case of Overwhelmingly Positive of Negative Results, Says Anthony Fauci

• SARS-CoV-2 Found in Blood Test on Hospital Admission Can Predict Severe COVID-19

• ThermoGenesis Launches Comprehensive Suite of COVID-19 Products and Services to Better Detect, Track and Fight Novel Coronavirus

• Minimal Mutation in SARS-CoV-2 Suggests Only One COVID-19 Vaccine May Be Sufficient to Combat Global Infections

• Study Finds Coronavirus Immunity Lasts Four Months after Infection, Offering Hope for COVID Vaccine Efforts

• Roche to Launch 15-Minute COVID-19 Rapid Antigen Test in Europe and File for EUA in US